Author details

Full Name

Lukas J A Stalpers

Affiliation

ORCID

Career Start Year

1987

Papers

201

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37306763	Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer: a feasibility study.		2023
37820768	Radiosensitization by Hyperthermia Critically Depends on the Time Interval.		2023
37568661	Selective Removal of Only Clinically Suspicious Positive Lymph Nodes Instead of a Complete Inguino-Femoral Lymph Node Dissection in Squamous Cell Carcinoma of the Vulva.		2023
38065242	The effectiveness of smoking cessation interventions after cancer diagnosis: A systematic review and meta-analysis.		2023
37185439	The Effect of Contemporary Brachytherapy Practices on Prognosis in Women with Locally Advanced Cervical Cancer.		2023
34419566	Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity Than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients.	Int J Radiat Oncol Biol Phys	2022
36355063	Comparison of the clinical performance of a hybrid Alba 4D and the AMC-4 locoregional hyperthermia systems.	International Journal of Hyperthermia	2022
35483738	Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.	International Journal of Gynecological Cancer	2022
35406443	A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors.	Cancers (Basel)	2022
35046082	The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review.	International Journal of Gynecological Cancer	2022
34773774	Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis - A review.		2022
34523836	[The mortality in Amsterdam from 1554 to 2021].	Nederlands Tijdschrift voor Geneeskunde	2021
34241726	The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review.	International Journal of Clinical Oncology	2021
33926008	PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.	Cancers	2021
31483520	Transceive phase mapping using the PLANET method and its application for conductivity mapping in the brain.	Magnetic Resonance in Medicine	2020
32138173	Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines.	Cancers	2020
32314825	Deep learning-based reconstruction of in vivo pelvis conductivity with a 3D patch-based convolutional neural network trained on simulated MR data.	Magnetic Resonance in Medicine	2020
32351897	Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer.	Frontiers in Oncology	2020
31982475	Molecular and biological rationale of hyperthermia as radio- and chemosensitizer.	Advanced Drug Delivery Reviews	2020
31977594	Re: Estimating the Population-level Effectiveness of Vaccination Programs in the Netherlands.	Epidemiology	2020
32806979	Advanced patient-specific hyperthermia treatment planning.	International Journal of Hyperthermia	2020
32523045	A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.	Nat Commun	2020
31341971	Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study.	Clin Transl Radiat Oncol	2019
31795835	Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.	Int J Hyperthermia	2019
31165046	The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer.	Frontiers in Oncology	2019
30737816	Accuracy and precision of electrical permittivity mapping at 3T: the impact of three mapping techniques.	Magnetic Resonance in Medicine	2019
30716525	Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033.	Int J Radiat Oncol Biol Phys	2019
29101415	Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.	Strahlenther Onkol	2018
28958992	Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.	Molecular Cancer Therapeutics	2018
28540821	Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i.	International Journal of Hyperthermia	2018
28540813	Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation.	International Journal of Hyperthermia	2018
30115874	Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents.	International Journal of Molecular Sciences	2018
30300028	Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments.	International Journal of Hyperthermia	2018
29869485	18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.	Quarterly Journal of Nuclear Medicine and Molecular Imaging	2018
29749270	The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose.	International Journal of Hyperthermia	2018
29276848	Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.	Acta Oncol	2018
29769103	The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.	Radiation Oncology	2018
29145750	Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia.	International Journal of Hyperthermia	2018
28108515	Prostate Cancer Patients with Late Radiation Toxicity Exhibit Reduced Expression of Genes Involved in DNA Double-Strand Break Repair and Homologous Recombination.	Cancer Res	2017
28434797	Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.	Radiother Oncol	2017
28427225	Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.	Oncotarget	2017
28449703	A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer.	Radiation Oncology	2017
28447562	Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy.	Acta Oncol	2017
28320338	The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.	BMC Cancer	2017
28870786	Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.	International Journal of Radiation Oncology Biology Physics	2017
29074259	Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.	Gynecologic Oncology	2017
27108291	B1-based SAR reconstruction using contrast source inversion-electric properties tomography (CSI-EPT).	Medical and Biological Engineering and Computing	2017
27744728	3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments.	International Journal of Hyperthermia	2017
27557507	Sensitizing thermochemotherapy with a PARP1-inhibitor.	Oncotarget	2017
28139418	Postoperative single-dose interstitial high-dose-rate brachytherapy in therapy-resistant keloids.		2017